Lack of an effect of zolmitriptan (Zomig, 311C90) on psychometric task performance: Results of a placebo-controlled study in healthy volunteers

Psychopharmacology

Volumn 140, Issue 4, 1998, Pages 398-404

  Mercer, A J ^a   Lamb, R J ^a   Rolan, P E ^b   Gibbens, M ^a   Posner, J ^c  

^a GLAXOSMITHKLINE   (United Kingdom)

^b Medeval Ltd   (United Kingdom)

^c Bios Ltd   (United Kingdom)

Author keywords

311C90; Lorazepam; Migraine 5 HT(1B 1D) agonist; Psychometric performance; Zolmitriptan

Indexed keywords

PLACEBO; ZOLMITRIPTAN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DATA ANALYSIS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HEADACHE; HUMAN; HUMAN EXPERIMENT; MALE; MENTAL PERFORMANCE; MIGRAINE; NAUSEA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROPHYLAXIS; PSYCHOMETRY; REACTION TIME; SEDATION; STATISTICAL ANALYSIS; VOLUNTEER;

ADOLESCENT; ADULT; AFFECT; ANTI-ANXIETY AGENTS; COLOR PERCEPTION; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LORAZEPAM; MALE; MENTAL PROCESSES; MIDDLE AGED; OXAZOLES; OXAZOLIDINONES; PSYCHOMETRICS; PSYCHOMOTOR PERFORMANCE; REACTION TIME; SEROTONIN AGONISTS; TRYPTAMINES;

EID: 0031702237     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050781     Document Type: Article

References (20)

1. Baddeley AD (1968) A three minute reasoning test based on grammatical transformation. Psychon Sci 10:341-342
2. Bond A, Lader M (1974) The use of analogue scales in rating subjective feelings. Br J Med Psychol 47:211-218
3. Borland R, Nicholson AN (1975) Comparison of the residual effects of two benzodiazepines (nitrazepam and flurazepam hydrochloride) and pentobarbitone on human performance. Br. J Clin Pharmacol 2:9-17
4. Ferrari MD (1996) The clinical effectiveness of 311C90 in the acute treatment of migraine. Eur Neurol 36 [Suppl 2]:4-7
5. Ferrari MD, Saxena PR (1992) Clinical effects and mechanism of sumitriptan in migraine. Clin Neurol Neurosurg 94 [Suppl]: 73-77
6. Ferrari MD, Saxena PR (1993) Clinical and experimental effects of sumatriptan in humans. Trends Pharmacol Sci 14:129-133
7. 1D agonist 311C90. Headache 34:299
8. Goldstein ME, Chen TC (1982) The epidemiology of disabling headache. Adv Neurol 33:377-390
9. Hindmarch I (1975) A 1,4-benzodiazepine, temazepam (IC3917), its effect on some psychological parameters of sleep and behaviour. Arzneimittelforschung 25:1836-1839
10. Hindmarch I (1981) Psychomotor function and psychoactive drugs. In: Lader M, Richens A (eds) Central nervous system. Macmillan, London and Basingstoke, pp 29-49
11. Humphrey PPA, Feniuk W (1991) Mode of action of the antimigraine drug sumatriptan. Trends Pharmacol Sci 12:444-445
12. Lloyd K (1994) The clinical profile of sumatriptan, safety and tolerability. Eur Neurol 34 [Suppl 2]:40-43
13. Martin GR, Maclennan SJ, Cambridge D, Whiting MV (1994) Effect of 311C90 on regional blood flows and systemic haemodynamics in anaesthetised dogs and eats. Headache 34:311
14. Moskowitz MA (1992) Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine. Trends Pharmacol Sci 13:307-311
15. Seaber E, On N, Philips S, Churchus R, Posner J, Rolan P (1996) The tolerability and pharmacokinetics of the novel antimigraine compound 311C90 in healthy male volunteers. Br J Clin Pharmacol 41:141-147
16. Seppala K, Korttila K, Hakkinen S, Linnoila M (1976) Residual effects and skills related to driving after a single oral administration of diazepam, medazepam or lorazepam. Br J Clin Pharmacol 3:831-841
17. Stroop JR (1935) Studies of interference in serial verbal reactions. J Exp Psychol 18:643-662
18. Tfelt-Hansen P, Johnson ES (1993) Ergotamine. In: Tfelt-Hansen P. Welch KMA (eds) The headaches. Raven Press, New York, pp 313-322
19. Tfelt-Hansen P, Lipton RB (1993) Dihydroergotamine. In: Tfelt-Hansen P, Welch KMA (eds) The headaches. Raven Press, New York, pp 323-327
20. 1D agonist in the acute oral treatment of migraine; a double-blind, placebo-controlled dose-range finding study. Neurology 46:522-526